Intrapulmonary delivery of hematopoietic drug
Patent Number: 6012450
Date of First Priority Issue: Tuesday March 5th, 1991
Date Issued: Tuesday January 11th, 2000
Assignee: Aradigm Corporation (Hayward, CA)
Inventor: Rubsamen, Reid M. (Berkeley, CA)
From Class: Administration
Comments: No comments
This patent teaches the administration of hematopoietic stem cell stimulatory factors through the intrapulmonary route. This patent is interesting in light of the fact that exogenous stem cells generally go to the liver or lung.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.